Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3903 |  RLYB Rallybio Corporation - Common Stock | 16.99 USD | +0.35% | +1.19% | +1.13% | +2989.09% | 90.23 M USD | ||
| 3904 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 0.48 USD | +2.13% | -14.29% | -60.00% | -74.87% | 90.19 M USD | ||
| 3907 |  CLLS Cellectis S.A. - American Depositary Shares | 1.25 USD | -6.72% | -13.79% | -59.55% | -70.24% | 89.69 M USD | ||
| 3908 |  PYPD PolyPid Ltd. - Ordinary Shares | 4.90 USD | -1.01% | -10.75% | -5.77% | +49.39% | 89.20 M USD | ||
| 3912 |  ICCC ImmuCell Corporation - Common Stock | 9.75 USD | +0.62% | +1.35% | -0.91% | +42.96% | 88.55 M USD | ||
| 3914 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 0.71 USD | -6.58% | -13.41% | -33.02% | -66.19% | 88.39 M USD | ||
| 3926 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.90 USD | -4.26% | -2.17% | -9.09% | -55.00% | 85.58 M USD | ||
| 3927 |  NRXS Neuraxis, Inc. Common Stock | 6.80 USD | -0.58% | -6.21% | +20.14% | +25.23% | 85.39 M USD | ||
| 3940 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.06 USD | -2.75% | -12.40% | +0.95% | -55.46% | 82.46 M USD | ||
| 3945 |  PMN ProMIS Neurosciences Inc. - Common Shares | 9.15 USD | +0.33% | -3.38% | -33.16% | +1659.62% | 82.05 M USD | ||
| 3959 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.87 USD | -0.53% | -8.78% | -7.88% | -5.08% | 80.14 M USD | ||
| 3964 |  PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.49 USD | -0.67% | -14.86% | +8.76% | +7.97% | 79.65 M USD | ||
| 3968 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.15 USD | +2.68% | -1.71% | -3.36% | -35.75% | 79.09 M USD | ||
| 3980 |  MNOV MediciNova, Inc. - Common Stock | 1.54 USD | -4.35% | -8.88% | -12.99% | +25.20% | 75.80 M USD | ||
| 3997 |  NTRB Nutriband Inc. - Common Stock | 6.05 USD | -10.50% | -18.90% | +5.03% | -14.79% | 73.54 M USD | ||
| 4002 |  OKYO OKYO Pharma Limited - American Depositary Shares | 1.39 USD | -2.80% | +4.51% | -0.71% | -34.43% | 72.95 M USD | ||
| 4017 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.18 USD | +0.97% | -13.64% | -17.39% | -30.56% | 71.81 M USD | ||
| 4020 |  CING Cingulate Inc. - Common Stock | 4.88 USD | +0.21% | +1.88% | -5.61% | -20.78% | 70.96 M USD | ||
| 4023 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.62 USD | -2.99% | -7.43% | -5.81% | -23.58% | 70.70 M USD | ||
| 4025 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.16 USD | 0.00% | -4.13% | -14.07% | -44.23% | 70.56 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |